title: Platelet GPIIb/IIIa antagonists: how safe is this antithrombotic approach?
authors.forename: S A
authors.initials: SA
authors.lastname: Mousa
authors.forename: W F
authors.initials: WF
authors.lastname: De Grado
authors.forename: T M
authors.initials: TM
authors.lastname: Reilly
mesh_terms: D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000077542:Eptifibatide; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use; D010980:Platelet Membrane Glycoproteins / Q000037:antagonists & inhibitors*; D013923:Thromboembolism / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010455:Peptides; D010980:Platelet Membrane Glycoproteins; D000077542:Eptifibatide; D000077284:Abciximab